OA and age
OA is a persistent, painful problem that has been linked to aging. Although younger people can develop the disease, it is more common in older people. And the percentage of people who have OA will grow larger as the population ages.
How did I get osteoarthritis?
OA can begin to break down your joints’ protective cartilage, causing pain and damage. As the bones rub together, pain, swelling and loss of motion in the joint increase.
Additionally, research suggests that OA also may be caused by an imbalance of the proteins that help regulate the condition of joint cartilage.
You don’t have to let OA control your life
Although there is no cure for osteoarthritis, you can fight OA joint pain with prescription treatment that helps to effectively manage your painful symptoms, so you can live your life without pain interrupting it.
Learn about a prescription medication you can rub in for relief that works directly at the site of the pain. Click here.
For U.S. Only
 To a friend |
|
 Add this page to your Facebook |
|
 Twitter this page |
|
 Digg this page |
|
 Add as a Del icio us bookmark |
|
 StumbleUpon this page |
Important Safety Information
*Voltaren® Gel is indicated for the relief of the pain of osteoarthritis of joints amenable to topical treatment, such as the knees and those of the hands. Voltaren Gel has not been evaluated for use on the spine, hip, or shoulder.
Cardiovascular Risk
- Nonsteroidal anti-inflammatory drugs (NSAIDs) may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk [see Warnings and Precautions].
- Voltaren Gel is contraindicated for the treatment of perioperative pain in the setting of coronary artery bypass graft (CABG) surgery [see Contraindications].
Gastrointestinal Risk
- NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events [see Warnings and Precautions].
The most common adverse reactions reported in Voltaren Gel clinical trials were application site reactions in 7% of treated patients. With all NSAIDs there may be an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal.
The use of Voltaren Gel is contraindicated in patients with a known hypersensitivity to diclofenac.
Voltaren Gel should not be administered in patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients.
Voltaren Gel should not be used in combination with other oral NSAIDs or aspirin because of the potential for increased adverse effects. Similarly, combined use of Voltaren Gel with other topical products, such as sunscreens and cosmetics, on the same skin area has not been tested and should be avoided because of the potential to alter local tolerability and absorption.
There is a potential for elevation in liver function tests during treatment with diclofenac containing products.
Safety and effectiveness in pediatric patients have not been established.
Please see full Prescribing Information for Warnings and Contraindications.
